May Approvals, More Questions
May 16, 2019•13 min
Episode description
Running through updated FDA approvals from this month (ivosidenib, T-DM1, ramucirumab, avelumab/axitinib, & venetoclax/obinutuzumab) and how these approvals raise more questions.
For the best experience, listen in Metacast app for iOS or Android
